Product NDC: | 65862-033 |
Proprietary Name: | Cefuroxime Axetil |
Non Proprietary Name: | Cefuroxime Axetil |
Active Ingredient(s): | 125 mg/1 & nbsp; Cefuroxime Axetil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-033 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065308 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060329 |
Package NDC: | 65862-033-60 |
Package Description: | 60 TABLET in 1 BOTTLE (65862-033-60) |
NDC Code | 65862-033-60 |
Proprietary Name | Cefuroxime Axetil |
Package Description | 60 TABLET in 1 BOTTLE (65862-033-60) |
Product NDC | 65862-033 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefuroxime Axetil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20060329 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | CEFUROXIME AXETIL |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |